Top Los Angeles, CA Biotech Companies (58)
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
Chinn Urology was founded primarily to serve as an aid towards prescription patients of all types and skill levels. While Chinn Urology is ever-expanding, our goal is always to provide patients with accurate, relevant medical guides, articles and more.
Molecular Instruments (MI) designs and synthesizes kits for multiplexed quantitative bioimaging in academic research, drug development, and clinical pathology and diagnostics. MI offers custom assay design and development services for life sciences and pharmaceutical companies.
Ocular is an Anti- Money Laundering (AML) compliance platform that provides instant verification of a customer`s background (KYC). The platform leverages cryptographic security mechanisms employed in distributed ledger technologies to ensure that data cannot be tampered with, while allowing users full control over how their data is stored and shared. The system is user-friendly for applicants while adhering to strict AML policy guidelines. Ocular integrates traditional name and personal data background checks with state-of-the-art identity verification mechanisms such as facial and voice recognition. This safeguards against ID theft, false registrations, Sybil attacks and other attacks which compromise and circumvent compliance. Ocular uses advanced technologies such as artificial intelligence (AI) and machine learning to dynamically monitor and upgrade its capabilities and defenses in the face of an ever-changing landscape of cyber security. The objective of Ocular is to provide parties a transparent mechanism to verify and validate one another, to prevent fraud and expose fraudulent activities. Ocular aim to be the de-facto standard for multi purpose, highly customizable and configurable solutions that bridges traditional finance with crypto and satisfies compliance requirements at the highest possible levels. The Ocular solution is the fastest way to achieve full AML compliance for your customers!
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With the team’s experience and scientific expertise in new drug development, Angitia is dedicated to bringing innovative therapeutics to help patients in need
Exsomed’s mission is to develop minimally-invasive, innovative solutions to enhance extremity implant procedures.
Founded in 1996, PSC Biotech Corporation was created with the vision of providing life science companies unmatched support. To date, PSC Biotech Corporation now serves 1000 clients in more than 35 countries worldwide through professional services consulting, cloud-based software solutions, pharmaceuticals contract manufacturing, life science investment consulting, and metrology services. PSC Biotech Corporation has six unique divisions within the parent company – each representing one of our areas of expertise: PSC Biotech, PSC Software, BioTechnique™, PSC Partners, PSC Metrology and PSC Investments. Additionally, PSC Asia and PSC Biotech Ltd represent PSC Biotech Corporation in Asia and Europe, respectively. Together, these divisions enable us to meet the ever-changing needs of our clients with a commitment to excellence and superior quality.
We aim to advance urologic patient care through bold innovation, based on diversity of thought, openness to new ideas, adaptation to change, integrity and compassion. We develop innovative therapies and participate in exceptional licensing opportunities. Our goal is to be the leading specialty company: recognized and trusted by patients and providers for our commitment to urology. Urologic conditions can have a major impact on daily life, with those affected often suffering in silence as their conditions are overlooked, misunderstood or not adequately treated. Read more about our community guidelines: https://urovant.com/community-guidelines/
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
ACELYRIN, INC. is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. ACELYRIN is embedding a corporate culture of Courageous Caring™—placing patients first and embracing the concept that all of us are better than any one of us. ACELYRIN addresses the most basic human needs—to live a productive life free from diseases.
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
OUR MISSION Our SeaSpine family is dedicated to collaborating with surgeons to develop cost effective solutions to treat spinal disorders. We do this by providing high quality, differentiated and complementary technologies that leverage our core competencies in orthobiologics, interbody devices and modular spinal instrumentation systems. OUR VISION We seek to be a marketshare-taker by driving improved procedural solutions that combine efficient spinal instrumentation systems with industry leading orthobiologics to deliver clinical value to the surgeon, hospital and patient.
Varda Space Industries was founded in 2020 with the goal of manufacturing products in space to benefit life on Earth. Co-founders Will Bruey and Delian Asparouhov imagined a world where space could be leveraged not only for storytelling and awe, but for its economic benefits. Varda was created as a platform for in-space manufacturing, with a range of real-life, on-Earth use cases. Today, we are accelerating innovation in space through our microgravity manufacturing platform, with applications including pharmaceuticals, hypersonic testing, and fiber optics. Varda is headquartered in El Segundo, California and has received venture funding from investors including Khosla Ventures, Lux Capital, Founders Fund, Caffeinated Capital, General Catalyst, and Also Capital.
Siragen Pharmaceuticals is an innovative biotechnology company.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. See our Community Guidelines: bit.ly/smcgl See our Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers.
AmpliPhi Biosciences is focused on developing novel bacteriophage-based therapeutics.
Tarsus is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients with unmet needs.
PBS Biotech aims to be the leading provider of innovative, single-use bioreactor systems specifically designed to address the unique challenges of cultivating shear sensitive cell types for cell therapy development. Our offering includes scalable, cost-effective disposable solutions designed to take you from benchtop R&D to large-scale cGMP manufacturing, and expert process development services to help solve cell culture challenges and accelerate your path to commercialization. To learn more, contact our sales team at [email protected] or visit our website at www.pbsbiotech.com
Viridos (formerly Synthetic Genomics, Inc) is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineersare shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com.
Work Your Passion. Live Your Purpose.
